Exodus Point Capital Management, LP Ultragenyx Pharmaceutical Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 87,017 shares of RARE stock, worth $3.71 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
87,017Holding current value
$3.71 Million% of portfolio
0.03%Shares
8 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
86.6MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$427 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$239 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$183 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$116 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$107 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.98B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...